相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
John M. M. Raemaekers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
Kieron Dunleavy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
Violaine Safar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care
Theodoros P. Vassilakopoulos et al.
ONCOLOGIST (2012)
Midtreatment 18F-Fluorodeoxyglucose Positron-Emission Tomography in Aggressive Non-Hodgkin Lymphoma
Pier Luigi Zinzani et al.
CANCER (2011)
Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients
Hee Kyung Ahn et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
Craig H. Moskowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Primary Mediastinal B-Cell Lymphoma
P. W.M. Johnson et al.
Hematology-American Society of Hematology Education Program (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease
Lale Kostakoglu et al.
CANCER (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience
KJ Savage et al.
ANNALS OF ONCOLOGY (2006)
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999
PA Hamlin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
K Spaepen et al.
ANNALS OF ONCOLOGY (2002)
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma
R Naumann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
MR Weihrauch et al.
BLOOD (2001)
分享论文
